Authors: SGOUROS G JUREIDINI IM SCOTT AM GRAHAM MC LARSON SM SCHEINBERG DA

Citation: G. Sgouros et al., BONE-MARROW DOSIMETRY - REGIONAL VARIABILITY OF MARROW-LOCALIZING ANTIBODY, The Journal of nuclear medicine, 37(4), 1996, pp. 695-698

Authors: SGOUROS G STABIN MG JUREIDINI IM SCOTT AS GRAHAM MC LARSON SM SCHEINBERG DA ECKERMAN KF

Citation: G. Sgouros et al., CLINICAL IMPLEMENTATION OF NEW REGION-SPECIFIC S-VALUES FOR MARROW DOSIMETRY - DOSE DISTRIBUTION VS MEAN MARROW DOSE IN RADIOIMMUNOTHERAPY OF LEUKEMIA, The Journal of nuclear medicine, 35(5), 1994, pp. 160000112-160000112

Authors: CARON PC JURCIC JG SCOTT AM FINN RD DIVGI CR GRAHAM MC JUREIDINI IM SGOUROS G TYSON D OLD LJ LARSON SM SCHEINBERG DA

Citation: Pc. Caron et al., A PHASE-1B TRIAL OF HUMANIZED MONOCLONAL-ANTIBODY M195 (ANTI-CD33) INMYELOID-LEUKEMIA - SPECIFIC TARGETING WITHOUT IMMUNOGENICITY, Blood, 83(7), 1994, pp. 1760-1768

Authors: CARON PC JURCIC JG SCOTT AM FINN RD DIVGI CR GRAHAM MC JUREIDINI IM SGOUROS G TYSON D OLD LJ LARSON SM SCHEINBERG DA

Citation: Pc. Caron et al., A PHASE-1B TRIAL OF HUMANIZED MONOCLONAL-ANTIBODY M195 (ANTI-CD33) INMYELOID-LEUKEMIA - SPECIFIC TARGETING WITHOUT IMMUNOGENICITY, Blood, 82(10), 1993, pp. 10000329-10000329